Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

Saved in:
Bibliographic Details
Title: Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.
Authors: Olawaiye, Alexander B.1 olawaiyea@upmc.edu, Jae-Weon Kim2, Bagameri, Andrea3, Bishop, Erin4, Chudecka-Głaz, Anita5, Devaux, Alix6, Gladieff, Laurence7, Gordinier, Mary E.8, Korach, Jacob9, McCollum, Michael E.10, Mileshkin, Linda11, Monk, Bradley J.12, Nicum, Shibani13, Nogueira-Rodrigues, Angélica14, Oaknin, Ana15, O'Malley, David M.16, Orlando, Mauro17, Dreiling, Lyndah18, Tudor, Iulia C.18, Lorusso, Domenica18
Source: Journal of Gynecologic Oncology. Jul2024, Vol. 35 Issue 4, p1-10. 10p.
Database: Academic Search Ultimate
Description
ISSN:20050380
DOI:10.3802/jgo.2024.35.e111